Quadrant Capital Group LLC Scholar Rock Holding Corp Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$11.89 - $24.68 $665 - $1,382	-56 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$27.38 - $42.21 $219 - $337	-8 Reduced 12.5%	56 $2,000
Q2 2021 Aug 09, 2021	SELL	$26.34 - $46.62 $579 - $1,025	-22 Reduced 25.58%	64 $2,000
Q1 2021 May 12, 2021	BUY	$45.96 - $68.02 $1,378 - $2,040	30 Added 53.57%	86 $4,000
Q3 2020 Nov 13, 2020	BUY	$10.54 - $18.47 $590 - $1,034	56 New	56 $1,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.